From perimenopause to post-menopause, we provide fast relief through evidence-based treatment.
Care providers
Expert virtual care to improve patient outcomes
Menopause-trained doctors and registered dietitian nutritionists (RDNs) as a virtual extension of your practice.
EASY ACCESS TO CARE
Help patients access menopause treatment 4x faster
The average wait time for an OB/GYN appointment is 31.4 days. At Gennev, patients get a video appointment with a menopause-trained OB/GYN within about a week.
- 30-minute video appointments
- Available in all 50 states
- Flexible scheduling options
WHY CHOOSE GENNEV
How we can enhance your practice
Specialty services
Offer your patients expert care with specialty services tailored to their symptoms and lifestyle.
Collaborative care
You’re the patient’s primary care provider, and after each appointment, we’ll share our notes with your practice.
Referrals
When our patients need in-person care, we refer them to a member of our network near them.
MENOPAUSE 201 SERIES
Monthly webinars led by our clinicians to enhance your knowledge of specialty menopause care
Upcoming clinician-led webinars
Webinar
Important Publications in Menopause Care: A Review of 2025The experts in menopause care
As menopause care rapidly evolves, staying up to date with new data is essential. This session will review the most impactful papers and advancements from 2025, highlighting what has changed in clinical practice and where evidence is still emerging. We’ll also discuss how to apply these findings in day-to-day patient care.
We’ll discuss these topics and take your questions in this 60-minute webinar.
January 22, 2026
Speakers: Dr. Rebecca Dunsmoor-Su
5:00 PM Pacific | 6:00 PM Mountain | 7:00 PM Central | 8:00 PM Eastern
Webinar
NK Receptor Antagonists: Physiology, Evidence, and Practical Prescribing
Neurokinin receptor antagonists represent a new frontier in managing vasomotor symptoms, but many clinicians are still navigating their role in practice. We will review the underlying physiology, summarize available safety and efficacy data, compare agents, and address insurance and access challenges. We’ll also walk through practical prescribing considerations.
We’ll discuss these topics and take your questions in this 60-minute webinar.
February 19, 2026
Speakers: Dr. Rebecca Dunsmoor-Su
5:00 PM Pacific | 6:00 PM Mountain | 7:00 PM Central | 8:00 PM Eastern
Webinar
Discussing Clot Risk and MHT: Evidence-Based Conversations
How should clinicians counsel patients about clot risk when considering menopausal hormone therapy? We’ll review the data on transdermal vs. oral estrogen, differing progestogens, and risk in special populations. We’ll also cover strategies for shared decision-making and communicating nuanced risk in a clear, supportive way.
We’ll discuss these topics and take your questions in this 60-minute webinar.
March 19, 2026
Speakers: Dr. Rebecca Dunsmoor-Su
4:00 PM Pacific | 5:00 PM Mountain | 6:00 PM Central | 7:00 PM Eastern
RDN REFERRALS
Offer your patients lifestyle and nutrition therapy
Our RDNs are experts in the menopause transition and work with various modalities for symptom relief and long-term health.
PROVEN HEALTH OUTCOMES
More than half of Gennev patients achieve symptom relief after one visit
97% of patients would refer a friend to Gennev
Covered by Insurance
We’re in- and out-of-network with these plans. Patients should check with their insurance provider about their Gennev coverage and deductible.